| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |